PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 40 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

13 May 2025

  1. (diff | hist) 02:41 Reconstitution of lyophilised peptides 5,243 ±0 LyophilLena (talk | contribs) the vial strength in the example was inconsistent between two paragraphs [rollback]
  2. (diff | hist) m 02:07 Repackaging 3,958 ±0 INN_Ingrid (talk | contribs) add the stopper material, since it affects moisture ingress [rollback]

12 May 2025

  1. (diff | hist) 18:18 Cold chain 21,309 +891 FmocFrancis (talk | contribs) unpipe a link that did not need piping [rollback]
  2. (diff | hist) 13:46 Mass spectrometry 5,248 ±0 IsocraticIla (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  3. (diff | hist) m 13:03 Bachem Holding (Suzhou) 10,353 ±0 VerifyVesna (talk | contribs) expand §External links [rollback]
  4. (diff | hist) 00:43 Medutest 3,830 +35 ChromCleanupCass (talk | contribs) correct the description of the sampling procedure [rollback]

11 May 2025

  1. (diff | hist) m 23:21 Certificate of analysis 8,593 +497 BlindSampleBrid (talk | contribs) add category for certificates of analysis [rollback]
  2. (diff | hist) m 21:07 Amylin receptor agonist 3,909 ±0 LiraLotte (talk | contribs) reorder the analogues chronologically rather than alphabetically [rollback]
  3. (diff | hist) 16:18 LEADER trial 3,566 +29 DMF_Dermot (talk | contribs) rm the cross-trial comparison; the populations are not comparable [rollback]
  4. (diff | hist) 14:45 High-performance liquid chromatography 6,203 +156 KarlFischerKit (talk | contribs) give the injection volume, without which the loading cannot be judged [rollback]
  5. (diff | hist) 13:15 GLP-1 receptor 6,670 +252 ExenatideEzra (talk | contribs) convert a hard-coded date to the house format [rollback]
  6. (diff | hist) 12:30 Patent expiry and biosimilars 3,580 ±0 StyleSheetSybil (talk | contribs) rm the speculation about future scheduling [rollback]
  7. (diff | hist) m 08:36 Melanotan II 3,694 +44 Peptide_Pete (talk | contribs) expand §Documented harms [rollback]
  8. (diff | hist) 05:08 Analytical method validation 5,074 +21 SemaglutideSasha (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  9. (diff | hist) 02:40 Amylin 4,252 ±0 ApoB_Aurelio (talk | contribs) add the structural figure and caption it properly [rollback]
  10. (diff | hist) 02:16 List of GLP-1 receptor agonists 3,410 +387 OrphanPageOrin (talk | contribs) consistent en dashes in ranges [rollback]

10 May 2025

  1. (diff | hist) 19:09 Hubei Jianxiang Bioscience 4,823 +1,955 UnderfillUna (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]
  2. (diff | hist) m 18:51 Flourishglobal Peptide Biotech 6,154 +634 DrTitration (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  3. (diff | hist) 18:42 Resin cleavage 3,304 +27 Chromatokid (talk | contribs) rm the blanket claim that excursions are harmless [rollback]
  4. (diff | hist) 14:25 Area percent purity 6,569 ±0 MassSpecMarv (talk | contribs) state the column chemistry and the gradient the figure was obtained on [rollback]
  5. (diff | hist) m b 13:02 GL Biochem (Shanghai) 14,304 +539 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  6. (diff | hist) 12:46 Peptide stability table 4,891 +847 DisclosureDido (talk | contribs) move a stray full stop inside the reference [rollback]
  7. (diff | hist) 03:15 Temperature excursion 5,832 +23 SurvodutideSaff (talk | contribs) add the light-exposure point for photosensitive material [rollback]

9 May 2025

  1. (diff | hist) m 22:36 Prior authorisation 3,517 +291 TelehealthTruus (talk | contribs) move a stray full stop inside the reference [rollback]
  2. (diff | hist) m b 21:55 Active pharmaceutical ingredient 3,755 +202 CategoryBot (talk | contribs) bot: update parent category chain [rollback]
  3. (diff | hist) 20:51 Solid-phase peptide synthesis 5,107 ±0 GHK_Gwendolen (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]
  4. (diff | hist) 12:50 HOMA-IR 3,431 ±0 FerritinFay (talk | contribs) state which fraction the assay actually measures [rollback]
  5. (diff | hist) 05:50 Trial data comparison 4,355 ±0 Ref_Desk_Ron (talk | contribs) state the rounding rule the readout uses [rollback]
  6. (diff | hist) 03:23 Grey market 3,184 ±0 KarlFischerKit (talk | contribs) state the difference between a validated shipper and an insulated box [rollback]

8 May 2025

  1. (diff | hist) 21:45 Drug master file 3,342 +30 NAION_Noel (talk | contribs) expand §How the mechanism works [rollback]
  2. (diff | hist) 21:26 Hypoglycaemia 3,775 +32 NauseaNoor (talk | contribs) clarify that dose-dependence is reported for some effects and not others [rollback]
  3. (diff | hist) 14:07 Vial 19,742 +506 HOMA_Hettie (talk | contribs) add the stopper material, since it affects moisture ingress [rollback]
  4. (diff | hist) m 11:44 Glucagon 6,042 +288 FreightFenna (talk | contribs) reorder the analogues chronologically rather than alphabetically [rollback]
  5. (diff | hist) 08:33 Talk:Shanghai ERP Biotechnology 959 +296 AnalyticalAnnie (talk | contribs) /* Endotoxin results: worth a paragraph? */ reply
  6. (diff | hist) 07:44 Tirzepatide 7,773 +1,201 MolarMassMaeve (talk | contribs) add a hatnote pointing at the analogue with the similar name [rollback]
  7. (diff | hist) 04:58 Good manufacturing practice 4,901 +982 ListMakerLumi (talk | contribs) clarify that personal importation and commercial importation are different questions [rollback]
  8. (diff | hist) 04:21 Baseline laboratory panel 3,542 +16 ApoB_Aurelio (talk | contribs) expand §Interpretation over time [rollback]
  9. (diff | hist) 02:01 Beta cell function 4,938 +22 Chromatokid (talk | contribs) add the cleavage site by residue number [rollback]

7 May 2025

  1. (diff | hist) m 23:53 Deamidation 4,219 ±0 IsocraticIla (talk | contribs) split overlong sentence [rollback]
  2. (diff | hist) m b 21:55 Beyond-use date 13,672 +541 StubSorterBot (talk | contribs) bot: repair redlinked category [rollback]
  3. (diff | hist) 20:51 Tianjin Finder Chemical 8,083 +456 ColdChainCleo (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  4. (diff | hist) 18:31 Prescribing information 4,324 +641 NauseaNoor (talk | contribs) add the note that list price is rarely what is paid [rollback]
  5. (diff | hist) m 17:54 Cold-chain freight 3,699 ±0 SupplyWatchSuri (talk | contribs) serial comma per PP:MOS [rollback]
  6. (diff | hist) m 15:04 SURPASS trial programme 4,474 ±0 OpenLabelOtto (talk | contribs) correct the endpoint hierarchy — that was a secondary endpoint [rollback]
  7. (diff | hist) 14:56 Janoshik Analytical 4,999 +30 SurpassSunniva (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  8. (diff | hist) m b 13:59 Peptide 5,710 +739 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  9. (diff | hist) 12:50 C-peptide 4,233 +775 UnitsUrsula (talk | contribs) convert the interval table to include both conventional and SI units [rollback]
  10. (diff | hist) 12:44 Talk:Shanghai ERP Biotechnology 748 +210 BlankVialBo (talk | contribs) /* Endotoxin results: worth a paragraph? */ reply
  11. (diff | hist) 09:18 Talk:Shanghai ERP Biotechnology 537 +266 EndotoxinEd (talk | contribs) /* Endotoxin results: worth a paragraph? */ new section
  12. (diff | hist) 09:11 Talk:Area percent purity 1,096 +74 StyleSheetSybil (talk | contribs) /* Should the four unseen categories be a definition list? */ reply
  13. (diff | hist) 08:24 ChinaPeptides 8,927 +1,017 SatietySunniva (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  14. (diff | hist) 08:02 Talk:Lyophilisation 959 +141 SigFigSindri (talk | contribs) /* Vapour-pressure table: source and rounding */ reply
  15. (diff | hist) m b 07:27 Counterfeit peptide 4,235 +233 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]

6 May 2025

  1. (diff | hist) 20:58 ISO 9001 3,379 +39 BalanceBirdie (talk | contribs) expand §What it implies about material [rollback]
  2. (diff | hist) 17:06 Cagrilintide 3,213 +26 LurkerLevi (talk | contribs) give the isoelectric point with the method it was determined by [rollback]
  3. (diff | hist) 16:44 Talk:Lyophilisation 748 +252 ColdChainCleo (talk | contribs) /* Vapour-pressure table: source and rounding */ reply
  4. (diff | hist) 14:18 Talk:Lyophilisation 537 +349 SigFigSindri (talk | contribs) /* Vapour-pressure table: source and rounding */ new section
  5. (diff | hist) 13:58 Talk:Area percent purity 885 +210 AnalyticalAnnie (talk | contribs) /* Should the four unseen categories be a definition list? */ reply
  6. (diff | hist) 11:43 Cost per milligram 3,122 ±0 Peptide_Pete (talk | contribs) add the harm-reduction cross-link [rollback]
  7. (diff | hist) m 11:30 Lot traceability 4,028 +26 AttributeAnders (talk | contribs) add the note on how to request a batch record rather than a certificate [rollback]
  8. (diff | hist) 10:22 Talk:Area percent purity 674 +200 StyleSheetSybil (talk | contribs) /* Should the four unseen categories be a definition list? */ new section
  9. (diff | hist) 09:36 Peptide harm reduction 3,975 +507 HarmReductionHen (talk | contribs) fix a dangling clause [rollback]
  10. (diff | hist) 05:19 Multi-dose vial 14,969 +2,480 SecondarySrc_Seb (talk | contribs) copyedit [rollback]
  11. (diff | hist) 03:06 Growth hormone secretagogue 3,620 ±0 SecretagogueSol (talk | contribs) add the molecular weight, calculated from the sequence and stated as such [rollback]
  12. (diff | hist) 03:00 Glucagon-like peptide-1 11,229 +977 BPC_Bramwell (talk | contribs) the numbers in the lead disagreed with the body; body was right [rollback]
  13. (diff | hist) m 02:35 Gastric emptying 4,652 +16 EndotoxinEd (talk | contribs) expand §Normal physiology [rollback]
  14. (diff | hist) m b 02:13 Shanghai Wibson Biotechnology 7,551 +1,145 StubSorterBot (talk | contribs) bot: add supplier category [rollback]
  15. (diff | hist) 00:13 PeptideMeter 3,902 +29 GroupBuyGalen (talk | contribs) de-orphan [rollback]

5 May 2025

  1. (diff | hist) 20:42 USP General Chapter 71 3,363 ±0 eGFR_Esme (talk | contribs) give the injection volume, without which the loading cannot be judged [rollback]
  2. (diff | hist) m 19:23 Personal importation policy 3,251 ±0 MassSpecMarv (talk | contribs) clarify the difference between a marketing authorisation and a registration [rollback]
  3. (diff | hist) 17:33 GLP-1 receptor agonist 9,758 +504 PurityClaimPia (talk | contribs) state plainly that the research-use-only form is not approved for human use [rollback]
  4. (diff | hist) 14:28 Trifluoroacetate counterion 3,899 ±0 KarlFischerKit (talk | contribs) add the system-suitability criteria the method actually specifies [rollback]
  5. (diff | hist) m 11:10 Guangzhou JEEP Biotechnology 11,377 ±0 GroupBuyGalen (talk | contribs) fix the anchor on an internal link [rollback]
  6. (diff | hist) 09:05 Orforglipron 4,505 +40 LiraLotte (talk | contribs) label the animal data as animal data in the sentence, not only in the section heading [rollback]
  7. (diff | hist) 08:49 Talk:Hubei Jianxiang Bioscience 1,033 +134 SupplyWatchSuri (talk | contribs) /* Dispatch address versus registered address */ reply
  8. (diff | hist) m 06:28 Sterile water for injection 4,413 +794 SurvodutideSaff (talk | contribs) expand §Compendial requirements [rollback]
  9. (diff | hist) m b 04:37 Adverse effects of GLP-1 receptor agonists 5,314 +17 CategoryBot (talk | contribs) bot: add maintenance category [rollback]
  10. (diff | hist) 01:17 Underfilling 3,432 ±0 SelectTrialSam (talk | contribs) split §What a report shows from §What it does not [rollback]

4 May 2025

  1. (diff | hist) m 20:35 Global access disparity 3,314 +114 CheckSumChase (talk | contribs) add the harm-reduction cross-link [rollback]
  2. (diff | hist) m 16:22 FLOW trial 3,481 ±0 AppendixAlva (talk | contribs) add the PMID [rollback]
  3. (diff | hist) 14:07 Blind sampling 6,780 ±0 UnderfillUna (talk | contribs) correct the description of how lot identifiers are assigned [rollback]
  4. (diff | hist) 13:53 USP General Chapter 85 4,270 ±0 ApoB_Aurelio (talk | contribs) add the note on co-elution and what it hides [rollback]
  5. (diff | hist) 13:32 Residual solvent 4,125 ±0 Areapercent_Ayo (talk | contribs) fix the anchor on an internal link [rollback]
  6. (diff | hist) m 10:34 Sarcopenia 3,713 +273 Ref_Desk_Ron (talk | contribs) clarify that the marker is method-dependent and not comparable across platforms [rollback]
  7. (diff | hist) 03:50 Contract development and manufacturing organisation 4,216 +412 FreightFenna (talk | contribs) expand §Consequences for reading documentation [rollback]

3 May 2025

  1. (diff | hist) 20:24 Arcuate nucleus 4,321 ±0 TimelineTiernan (talk | contribs) expand §Neuronal populations [rollback]
  2. (diff | hist) m b 19:40 WuXi TIDES 11,332 +673 ArchiveBot (talk | contribs) bot: add supplier category [rollback]
  3. (diff | hist) 18:25 Exenatide 4,449 ±0 IncretinIvo (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]
  4. (diff | hist) m 13:48 Haemoglobin A1c 3,396 +30 RegainRomilly (talk | contribs) clarify that the marker is method-dependent and not comparable across platforms [rollback]
  5. (diff | hist) 12:25 Chinese Peptide Company 11,789 +968 ChainCustodyChad (talk | contribs) add the transit window each regional warehouse serves [rollback]
  6. (diff | hist) m b 11:39 Reference standard 4,154 ±0 CategoryBot (talk | contribs) bot: flag bare reference [rollback]
  7. (diff | hist) m b 10:27 Amino acid analysis 4,038 ±0 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  8. (diff | hist) 09:26 Talk:Hubei Jianxiang Bioscience 822 +182 NPOV_Nadia (talk | contribs) /* Dispatch address versus registered address */ reply
  9. (diff | hist) m 07:30 Xi'an Mokemei Biotechnology 5,086 +335 LabRangeLindy (talk | contribs) state the city and province of the registered address [rollback]
  10. (diff | hist) m b 07:25 Fmoc chemistry 4,430 ±0 CategoryBot (talk | contribs) bot: update parent category chain [rollback]
  11. (diff | hist) m 06:12 Proglucagon 5,743 ±0 GIP_Genoveva (talk | contribs) add the postprandial time course with its units [rollback]

2 May 2025

  1. (diff | hist) 22:48 MOTS-c 3,340 +30 MissedDoseMik (talk | contribs) state which receptor subtype the binding data refers to [rollback]
  2. (diff | hist) 21:02 Fasting insulin 3,216 ±0 ResolutionRoo (talk | contribs) expand §Standardisation [rollback]
  3. (diff | hist) 19:25 TRIUMPH trial programme 4,014 ±0 ProglucagonPia (talk | contribs) ce per PP:MOS [rollback]
  4. (diff | hist) 13:44 Talk:Hubei Jianxiang Bioscience 611 +202 CustomsClarke (talk | contribs) /* Dispatch address versus registered address */ reply